A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks is effective: A Belgian prospective study
(2004) Annual European Congress of Rheumatology (EULAR 2004) — Location: Berlin (Germany) (9.June.2004)
